PATENT CLAIM ANALYSIS

Application Number: 16204584
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "300000"]

Abstract:
The present invention includes novel substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, which can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention inhibit HBV RNAse H activity.

Claim (Index 15):
The method of  claim 13 , wherein the subject is co-administered the at least one compound and the at least one additional agent.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.12821
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16204748', '15738734', '14361278', '12747109', '10587682']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7473141523909433
- 35 USC 102 Novelty (BERT): 0.5253263201963706
- Combined Prediction Score: 0.7251153691714861
- Mean Citation Score: 285.7352
- Max Citation Score: 326.30392
- Similarity Product: 285.49790056449416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test